Your browser is no longer supported. Please, upgrade your browser.
Settings
MYL Mylan N.V. daily Stock Chart
MYL [NASD]
Mylan N.V.
IndexS&P 500 P/E189.52 EPS (ttm)0.11 Insider Own1.35% Shs Outstand510.69M Perf Week-6.48%
Market Cap10.16B Forward P/E4.41 EPS next Y4.51 Insider Trans-0.17% Shs Float509.21M Perf Month-8.92%
Income54.30M PEG40.91 EPS next Q1.28 Inst Own88.80% Short Float4.72% Perf Quarter14.57%
Sales11.39B P/S0.89 EPS this Y-57.40% Inst Trans-1.01% Short Ratio4.01 Perf Half Y8.51%
Book/sh22.22 P/B0.90 EPS next Y4.98% ROA0.10% Target Price25.31 Perf Year-35.74%
Cash/sh0.83 P/C24.06 EPS next 5Y4.63% ROE0.40% 52W Range16.63 - 31.58 Perf YTD-1.00%
Dividend- P/FCF6.78 EPS past 5Y-16.70% ROI3.50% 52W High-37.92% Beta1.68
Dividend %- Quick Ratio0.80 Sales past 5Y10.60% Gross Margin39.40% 52W Low17.89% ATR0.73
Employees35000 Current Ratio1.40 Sales Q/Q3.50% Oper. Margin5.90% RSI (14)33.23 Volatility3.39% 3.04%
OptionableYes Debt/Eq1.14 EPS Q/Q22.20% Profit Margin0.40% Rel Volume0.64 Prev Close19.90
ShortableYes LT Debt/Eq1.09 EarningsFeb 27 AMC Payout0.00% Avg Volume6.00M Price19.60
Recom2.30 SMA20-9.81% SMA50-6.66% SMA2000.82% Volume3,567,538 Change-1.48%
Jan-27-20Downgrade SVB Leerink Outperform → Mkt Perform $24
Jan-09-20Initiated Piper Sandler Neutral $21
Nov-07-19Downgrade Morgan Stanley Overweight → Equal-Weight
Nov-05-19Downgrade CFRA Hold → Sell
Jul-19-19Initiated Wolfe Research Outperform
Jun-11-19Initiated Barclays Overweight $26
May-08-19Downgrade Wells Fargo Outperform → Market Perform $33 → $22
Mar-20-19Initiated SunTrust Buy $35
Mar-07-19Resumed UBS Neutral $31
Mar-06-19Upgrade Morgan Stanley Equal-Weight → Overweight $35
Feb-27-19Downgrade Bernstein Outperform → Mkt Perform $33
Jan-23-19Downgrade UBS Buy → Neutral
Nov-15-18Upgrade Argus Hold → Buy
Nov-06-18Upgrade BofA/Merrill Neutral → Buy
Oct-09-18Downgrade Morgan Stanley Overweight → Equal-Weight
Oct-05-18Downgrade Mizuho Buy → Neutral
Aug-24-18Upgrade Evercore ISI In-line → Outperform
Aug-13-18Upgrade RBC Capital Mkts Sector Perform → Outperform
Apr-12-18Upgrade Leerink Partners Mkt Perform → Outperform
Mar-15-18Reiterated Mizuho Buy $45 → $51
Feb-26-20 08:46AM  Is a Surprise Coming for Mylan (MYL) This Earnings Season? Zacks
Feb-25-20 02:53PM  Theravance (TBPH) Q4 Earnings Miss, Revenues Beat Estimates Zacks
Feb-24-20 12:41PM  The Zacks Analyst Blog Highlights: Johnson & Johnson, Bayer Aktiengesellschaft, Pfizer, Mylan N.V. and Teva Pharmaceutical Industries Zacks
08:00AM  Pfizer Stock Tumbled On Lackluster Earnings Should You Add Shares? Investor's Business Daily
Feb-21-20 09:16AM  3 Best Drugmakers That Are Immune to Coronavirus Fright Zacks
Feb-20-20 12:31PM  Mylan (MYL) Expected to Beat Earnings Estimates: Should You Buy? Zacks
Feb-19-20 10:37AM  Merck KGaA sells allergy unit to Dermapharm, keeps autoinjector project Reuters
Feb-18-20 11:24AM  Mylan-Upjohn merger filings contemplate coronavirus impact American City Business Journals
09:02AM  Mylan (MYL) to Report Q4 Earnings: What's in the Offing? Zacks
07:30AM  Mylan to Release 2019 Fourth Quarter, Full Year Results and 2020 Guidance on Feb. 27, 2020 PR Newswire
Feb-14-20 12:00PM  Pharma Stock's Rally Could Have Legs Schaeffer's Investment Research
Feb-10-20 10:20AM  What's in Store for Acorda (ACOR) This Earnings Season? Zacks
Feb-07-20 05:30PM  Steven Romick Ups Short-Selling in 4th Quarter GuruFocus.com
10:28AM  Teva (TEVA) to Report Q4 Earnings: What's in the Cards? Zacks
Feb-06-20 11:53AM  Biogen Soars on Patent Win for MS Drug Tecfidera Over Mylan Zacks
11:00AM  Glaxo (GSK) Lags Q4 Earnings & Revenue Estimates, Stock Down Zacks
10:10AM  Mylan Breaks Out on the Upside From a 9-Month Base Pattern TheStreet.com
06:37AM  Biogen shares rise as drugmaker avoids worst case scenario in patent dispute American City Business Journals
Feb-05-20 04:21PM  Biogen Rockets Into A Breakout After Beating Mylan In A Patent Battle Investor's Business Daily
03:16PM  Biogen Beats Back Mylan Patent Challenge Over MS Drug Tecfidera TheStreet.com
02:59PM  Biogen's stock jump 19% on Tecfidera patent ruling MarketWatch
02:13PM  Biogen Stock Skyrockets on Major Patent Win Barrons.com
10:27AM  Theravance Pipeline Strong, Dependence on Yupelri a Concern Zacks
09:35AM  Biogen Sees Huge Bounce on MS Drug Patent Ruling Investing.com
03:40AM  Biogen shares soar after patent victory Financial Times
Feb-03-20 10:50PM  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BZUN, MYL, OPRA, WBK INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
11:39AM  Biogen Investors Face Next Test With Pending Drug Patent Ruling Bloomberg
Jan-31-20 10:50PM  SHAREHOLDER ALERT: CLAIMSFILER REMINDS FSCT, MAT, MYL, TCNNF INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
Jan-29-20 10:50PM  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BZUN, FCAU, MYL, OPRA INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
Jan-28-20 10:50PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BZUN, MAT, MYL and TCNNF GlobeNewswire
10:31AM  Pfizer (PFE) Lags Q4 Earnings & Sales Estimates, Stock Down Zacks
06:58AM  Pfizer Misses Q4 Earnings Forecast TheStreet.com
06:54AM  Pfizer posts 9% fall in fourth-quarter revenue Reuters
03:58AM  Stocks - Harley, Pfizer, 3M Slump in Premarket; Delphi Tech Soars Investing.com
Jan-27-20 10:50PM  SHAREHOLDER ALERT: CLAIMSFILER REMINDS FSCT, MAT, MYL, TCNNF INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
12:10PM  Why the Earnings Surprise Streak Could Continue for Mylan (MYL) Zacks
11:50AM  Should Value Investors Buy Mylan (MYL) Stock? Zacks
10:28AM  Mylan Stock Is Falling Because the Upjohn Deal Wont Soon Help Earnings, Analyst Says Barrons.com
07:42AM  Top Ranked Value Stocks to Buy for January 27th Zacks
Jan-24-20 10:50PM  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BZUN, FCAU, MYL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
01:50PM  New partnership aims to ease surging generic drug costs by making its own Yahoo Finance
Jan-23-20 08:46AM  Pfizer (PFE) Q4 Earnings Coming Up: What's in the Cards? Zacks
Jan-22-20 10:50PM  SHAREHOLDER ALERT: CLAIMSFILER REMINDS FSCT, MAT, MYL, TCNNF INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
Jan-21-20 10:50PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BZUN, MAT, MYL and TCNNF GlobeNewswire
Jan-20-20 10:50PM  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BZUN, FCAU, MYL, PRU INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
12:50PM  Steven Romick Exits Mylan, Cuts Bank of America GuruFocus.com
09:40AM  Should Value Investors Consider Mylan N.V. (MYL) Stock? Zacks
Jan-17-20 10:50PM  SHAREHOLDER ALERT: CLAIMSFILER REMINDS FSCT, MAT, MYL, TCNNF INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
08:34AM  S&P 500 Up 1000 Points in a Month: 10 Stocks Boosted the ETF Zacks
08:00AM  10 Top-Ranked S&P 500 Stocks Outperforming in 2020 Zacks
Jan-15-20 10:50PM  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BZUN, FSCT, MAT, MYL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
10:24AM  Democrats Called for Cuts to Drug Prices at the Debate. The Pharma Industry Says Its Trying. Barrons.com
10:02AM  3 Healthcare Stocks That Are Coming Back to Life TipRanks
Jan-14-20 10:50PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BZUN, MAT, MYL and TCNNF GlobeNewswire
01:07PM  Mylan Inc. -- Moody's announces completion of a periodic review of ratings of Mylan N.V. Moody's
Jan-13-20 10:50PM  SHAREHOLDER ALERT: CLAIMSFILER REMINDS FSCT, MATT, MYL, TCNNF INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
Jan-10-20 08:05PM  Biogen Defends Its Blockbuster Against Mylans Patent Challenge Barrons.com
11:50AM  Is Mylan (MYL) a Great Value Stock Right Now? Zacks
07:06AM  3 Big Stock Charts for Friday: Square, American Airlines, and Kinder Morgan InvestorPlace
Jan-09-20 10:05AM  Viatris Will Be the New Kid in Generic Drugs. Dont Expect the Stock to Surge, Analyst Says. Barrons.com
Jan-08-20 10:50PM  SHAREHOLDER ALERT: CLAIMSFILER REMINDS BZUN, MAT, MYL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
04:35PM  Mylan Stock Rebounds After Pharma Giant Recalls Contaminated Ulcer Drugs Investor's Business Daily
10:30AM  Mylan Initiates Voluntary Nationwide Recall of Three Lots of Nizatidine Capsules, USP, Due to the Detection of Trace Amounts of NDMA (N-Nitrosodimethylamine) Impurity Found in the Active Pharmaceutical Ingredient Manufactured by Solara Active Pharma Sciences Limited PR Newswire
Jan-07-20 10:50PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BZUN, MATT and MYL GlobeNewswire
Jan-06-20 10:50PM  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BZUN, MATT, MYL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
10:12AM  MYL INVESTOR ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Against Mylan N.V. ACCESSWIRE
09:38AM  Biogen Faces a Looming Patent Decision. Heres How Much Its Stock Could Drop If It Loses. Barrons.com
07:30AM  Mylan to Present at the 38th Annual J.P. Morgan Healthcare Conference PR Newswire
Jan-03-20 10:50PM  SHAREHOLDER ALERT: CLAIMSFILER REMINDS BZUN, FCAU, MYL, REAL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
01:38PM  After Lackluster 2019, Pfizer Stock Could Rebound in 2020 InvestorPlace
07:40AM  Stay on the Sidelines as the Future Looks Potentially Bleak for Teva Stock InvestorPlace
Jan-02-20 10:45AM  CLASS ACTION UPDATE for REAL, MYL and PLT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
Jan-01-20 10:50PM  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BZUN, MYL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
06:06AM  Those Who Purchased Mylan (NASDAQ:MYL) Shares Five Years Ago Have A 64% Loss To Show For It Simply Wall St.
12:48AM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BZUN and MYL GlobeNewswire
Dec-31-19 10:45AM  CLASS ACTION UPDATE for REAL, AZZ and MYL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
Dec-30-19 10:50PM  SHAREHOLDER ALERT: CLAIMSFILER REMINDS BZUN, FCAU, MYL, REAL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
10:45AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TWTR, MYL and AFI ACCESSWIRE
08:57AM  MYL INVESTOR ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Against Mylan N.V. ACCESSWIRE
Dec-29-19 10:45AM  SHAREHOLDER ALERT: WSG UA MYL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
Dec-27-19 10:50PM  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BZUN, MYL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
09:25AM  Pfizer (PFE) Sees a Difficult 2019: Can it Rebound in 2020? Zacks
09:24AM  Is Mylan (MYL) Doomed to Witness a Terrible 2020 Too? Zacks
Dec-26-19 11:11AM  How Did Mylan N.V. (MYL) Compare Against Hedge Fund Darlings in 2019? Insider Monkey
10:45AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of UNIT, MYL and GRUB ACCESSWIRE
Dec-25-19 10:50PM  SHAREHOLDER ALERT: CLAIMSFILER REMINDS BZUN, MYL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
Dec-24-19 10:50PM  FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BZUN, MYL and UNIT GlobeNewswire
10:55AM  CLASS ACTION UPDATE for MYL, TIGR and BZUN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
10:41AM  Year in Review: Mylan NV to become one of largest in its field American City Business Journals
09:49AM  Mylan, Micro Labs receive FDA approval to market generic Eliquis MarketWatch
05:37AM  Mylan Shares Steady as FDA Approves Generic Version of Anti-Stroke Medication Eliquis TheStreet.com
Dec-23-19 10:50PM  SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BZUN, MYL, UNIT INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
10:55AM  CLASS ACTION UPDATE for MYL, YJ and HEXO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
09:50AM  MYL INVESTOR ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Against Mylan N.V. ACCESSWIRE
Dec-21-19 04:51PM  These 10 S&P 500 stocks were lousy in 2019, but they could return 40% or more in 2020 MarketWatch
Dec-20-19 10:50PM  MYLAN SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Mylan N.V. - MYL Business Wire
06:55PM  CLASS ACTION UPDATE for UNIT, TWTR and MYL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
04:01PM  IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mylan N.V. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
03:15PM  SHAREHOLDER ALERT: INFY IRBT MYL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
12:56PM  Shareholder Alert: Robbins LLP Announces Mylan N.V. (MYL) Sued for Misleading Shareholders Business Wire
Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded-generic, brand-name, and over-the-counter (OTC) pharmaceutical products in North America, Europe, and internationally. It offers active pharmaceutical ingredients and finished dosage forms; and antiretroviral medicines to treat HIV/AIDS. The company also provides prescription products, such as EpiPen Auto-Injector; Perforomist Inhalation Solution; Dymista; Creon; and Influvac, as well as YUPELRI, an inhalation solution for the maintenance treatment of patients with chronic obstructive pulmonary diseases. In addition, it markets OTC products, including Cold-EEZE, MidNite, Vivarin, Brufen, CB12, and EndWarts. The company offers its products to therapeutic areas, such as cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, gastroenterology, immunology, infectious disease, oncology, respiratory and allergy, and women's health. Its customers include retail pharmacies, wholesalers and distributors, payers, and insurers and governments, as well as institutions, such as hospitals. Mylan N.V. has collaboration and license agreements with Pfizer Inc.; Momenta Pharmaceuticals, Inc.; TB Alliance; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. The company was founded in 1961 and is based in Hatfield, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Campbell PaulSee RemarksFeb 05Sale23.0011,611267,05325,413Feb 07 06:00 PM
HIGGINS MELINA EDirectorAug 15Buy17.6820,000353,54833,120Aug 19 07:29 PM
Vollebregt Sjoerd SDirectorAug 14Buy18.8124,000451,43942,258Aug 15 06:30 PM
Vollebregt Sjoerd SDirectorAug 13Buy19.1110,000191,10018,258Aug 15 06:30 PM
COURY ROBERT JDirectorAug 02Buy20.0649,8591,000,012947,194Aug 05 08:00 AM
MARK RICHARD ADirectorJul 31Buy20.974,00083,8744,000Aug 02 06:48 PM
COURY ROBERT JDirectorJun 24Option Exercise0.00750,00001,309,835Jun 25 08:04 PM
Gallagher Daniel Martin JrChief Legal OfficerApr 01Option Exercise0.008,515021,133Apr 03 06:00 PM
Campbell PaulSee RemarksMar 04Sale27.5011,533317,14324,137Mar 05 06:15 PM
Campbell PaulSee RemarksMar 03Option Exercise0.002190599Mar 05 06:15 PM
Campbell PaulSee RemarksMar 03Option Exercise0.00830024,493Mar 05 06:15 PM
Parks Kenneth ScottChief Financial OfficerMar 03Option Exercise0.003,984016,853Mar 05 06:13 PM
Malik RajivPresidentMar 03Option Exercise0.0012,3950275,388Mar 05 06:11 PM
Mauro AnthonyChief Commercial OfficerMar 03Option Exercise0.005,534098,537Mar 05 06:11 PM
Gallagher Daniel Martin JrChief Legal OfficerMar 03Option Exercise0.008,218016,567Mar 05 06:09 PM
BRESCH HEATHER MChief Executive OfficerMar 03Option Exercise0.0020,1420394,503Mar 05 06:06 PM
Vollebregt Sjoerd SDirectorMar 02Option Exercise0.004,02808,258Mar 05 06:33 PM
VANDERVEEN RANDALL LDirectorMar 02Option Exercise0.004,028045,845Mar 05 06:30 PM
van der Meer Mohr PaulineDirectorMar 02Option Exercise0.004,56604,566Mar 05 06:27 PM
PARRISH MARK WDirectorMar 02Option Exercise0.004,028041,423Mar 05 06:25 PM
KORMAN HARRYDirectorMar 02Option Exercise0.004,566024,816Mar 05 06:23 PM
HIGGINS MELINA EDirectorMar 02Option Exercise0.004,028013,120Mar 05 06:22 PM
DIMICK NEIL FDirectorMar 02Option Exercise0.004,028048,645Mar 05 06:21 PM
Lyons Dillon JoEllenDirectorMar 02Option Exercise0.004,028013,667Mar 05 06:20 PM
Cindrich Robert JDirectorMar 02Option Exercise0.004,028023,107Mar 05 06:16 PM
Campbell PaulSee RemarksMar 02Option Exercise0.001670437Mar 05 06:15 PM
Campbell PaulSee RemarksMar 02Option Exercise0.001,980024,540Mar 05 06:15 PM
Parks Kenneth ScottChief Financial OfficerMar 02Option Exercise0.006,103015,541Mar 05 06:13 PM
Malik RajivPresidentMar 02Option Exercise0.0014,6450269,457Mar 05 06:11 PM
Mauro AnthonyChief Commercial OfficerMar 02Option Exercise0.006,103095,657Mar 05 06:11 PM
Gallagher Daniel Martin JrChief Legal OfficerMar 02Option Exercise0.007,811012,093Mar 05 06:09 PM
BRESCH HEATHER MChief Executive OfficerMar 02Option Exercise0.0022,2120384,223Mar 05 06:06 PM